The following trials provide information to treat various types of disease of the brain and the central and local nervous systems, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
-
expand
A Retrospective, Non-interventional Study to Evaluate the Use of Seroquel XR and Seroquel IR in the Clinical Practice of Outpatients With Schizophrenia
- Study Id
- NIS-NDK-SER-2010/2
- Disease
- schizophrenia
- Drug Name
- Seroquel XR
- Study Name
- NIS-NDK-SER-2010/2
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jan 18, 2012
-
expand
An open label Positron Emission Tomography (PET) study with [11C]AZ12713580 to determine central mGluR5 receptor occupancy of AZD2516 after oral administration to healthy subjects
- Study Id
- D2080C00009
- Disease
- analgaesia
- Drug Name
- AZD2516
- Study Name
- D2080C00009
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Apr 9, 2010
-
expand
A Phase I, Single-centre, Randomised, Double-blind, Placebo-controlled Parallel group Study to Assess the Safety, Tolerability and Pharmacokinetics after Oral Single Ascending Doses of AZD2516 in Young and Elderly Japanese Healthy Subjects
- Study Id
- D2080C00004
- Disease
- analgaesia
- Drug Name
- AZD2516
- Study Name
- D2080C00004
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Mar 12, 2010
-
expand
A Single Centre Two Part Randomized Phase I Study to Assess the Pharmacokinetics of an ER Formulation of AZD2516 and to Assess the Safety, Tolerability and Pharmacokinetics of AZD2516 After Multiple Ascending Doses in Healthy Volunteers
- Study Id
- D2080C00002
- Disease
- pain
- Drug Name
- AZD2516
- Study Name
- D2080C00002
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jan 24, 2011
-
expand
Phase I, Single-centre, Randomised, Double-blind, Placebo-controlled Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2516 in Young and Elderly Healthy Volunteers after Oral Single Ascending Doses
- Study Id
- D2080C00001
- Disease
- analgaesia
- Drug Name
- AZD2516
- Study Name
- D2080C00001
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Feb 23, 2009
-
expand
A phase IIa, double-blind, randomized, 2-way cross-over study to evaluate the effect of a single dose of AZD1386 95 mg compared to placebo in a multimodal experimental pain model on esophageal sensitivity in GERD patients with a partial response to PPI treatment
- Study Id
- D9127C00002
- Disease
- analgaesia
- Drug Name
- AZD1386
- Study Name
- D9127C00002
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jun 28, 2011
-
expand
A double-blind, randomized, placebo-controlled, single-centre phase I pharmacodynamic cross-over study to assess the efect of a single dose of AZD2066 oral solution in comparison to placebo on transient lower esophageal sphincter relaxations (TLESRs) in healthy subjects
- Study Id
- D9126C00001
- Disease
- analgaesia
- Drug Name
- AZD2066
- Study Name
- D9126C00001
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
May 6, 2010
-
expand
A Phase I, Single-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD7268 after Single Ascending Oral Doses in Healthy Subjects
- Study Id
- D1151C00001
- Disease
- anxiety, depression
- Drug Name
- AZD7268
- Study Name
- D1151C00001
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jul 13, 2009
-
expand
A Phase I, Single-Centre, Randomised, Double-Blind, Placebo-controlled, Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7268 When Given in Multiple Ascending Oral Doses in Japanese Healthy Male Subjects
- Study Id
- D1151C00004
- Disease
- depression
- Drug Name
- AZD7268
- Study Name
- D1151C00004
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Sep 22, 2010
-
expand
A Phase I, Single Center, Randomized, Double-Blind, Placebo-Controlled Single Ascending Oral Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7268 in Healthy Japanese Subjects
- Study Id
- D1151C00002
- Disease
- anxiety, depression
- Drug Name
- AZD7268
- Study Name
- D1151C00002
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Feb 26, 2010
